Amylin Has Rejected $3.5 Billion Buyout Bid By Bristol-Myers -Bloomberg
March 28 2012 - 10:08AM
Dow Jones News
Amylin Pharmaceuticals Inc. (AMLN) has rejected an unsolicited
$3.5 billion offer from Bristol-Myers Squibb Co. (BMY), made
earlier this year, Bloomberg News reported Wednesday, citing two
people with knowledge of the matter.
Bristol-Myers had offered $22 a share for the drug maker.
Amylin's board last month turned down the proposal, Bloomberg
reported. The stock closed Tuesday at $15.39.
Full story at:
www.bloomberg.com/news/2012-03-28/mylin-said-to-have-spurned-3-5-billion-bristol-myers-bid.html
-Dow Jones Newswires; 212-416-2900
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Apr 2023 to Apr 2024